Table 2.

Treatment-related adverse events (n = 22)

Adverse event	Number (%)
	Grade 1	Grade 2	Grade 3	Grade 4
Akathisia	1 (5)	0	0	0
Alkaline phosphatase increases	1 (5)	1 (5)	0	0
Allergic rhinitis	1 (5)	0	0	0
ALT increased	2 (9)	1 (5)	0	0
AST increased	1 (5)	0	0	0
Arthralgia	0	1 (5)	0	0
Chills	1 (5)	0	0	0
Diarrhea	1 (5)	1 (5)	0	0
Elevated amylase and/or lipase	0	0	1 (5)	0
Fatigue	7 (32)	0	0	0
Fever	3 (14)	0	0	0
Flu-like symptoms	2 (9)	0	0	0
Gamma glutamyl ­transferase increased	0	0	2 (9)	0
Headache	1 (5)	0	0	0
Hypothyroidism	1 (5)	0	0	0
Hyperglycemia	1 (5)	0	0	0
Infusion reaction	1 (5)	6 (27)	0	0
Lymphopenia	2 (9)	0	1 (5)	0
Myalgia	0	1 (5)	0	0
Nausea	3 (14)	0	0	0
Night sweats	1 (5)	0	0	0
PRESS	0	0	1 (5)	0
Rash-maculopapular	0	1 (5)	0	0
Rigors	1 (5)	0	0	0
Site administration erythema	1 (5)	0	0	0
Vomiting	1 (5)	0	0	0
Weight loss	0	1 (5)	0	0